Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
helen.sheldon@well.ox.ac.uk

Research groups

Church group: tumour genomics and immunology

Helen Sheldon

Senior Scientist/Lab Manager,

Recent publications

ELTD1 is present in extracellular vesicles derived from endothelial cells as a cleaved extracellular domain which induces in vivo angiogenesis.

Sheldon H. et al, (2022), Journal of extracellular biology, 1

ADGRL4/ELTD1 Expression in Breast Cancer Cells Induces Vascular Normalization and Immune Suppression.

Sheldon H. et al, (2021), Molecular cancer research : MCR, 19, 1957 - 1969

ELTD1 Activation Induces an Endothelial-EMT Transition to a Myofibroblast Phenotype.

Sheldon H. et al, (2021), International journal of molecular sciences, 22

Elevated expression of the adhesion GPCR ADGRL4/ELTD1 promotes endothelial sprouting angiogenesis without activating canonical GPCR signalling.

Favara DM. et al, (2021), Scientific reports, 11

ELTD1 Activation Induces an Endothelial-EMT Transition to a Myofibroblast Phenotype

Sheldon H. et al, (2021)